Avadel Pharmaceuticals to Present at the Ladenburg Thalmann Healthcare Conference

DUBLIN, Ireland, Sept. 22, 2022 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Ladenburg Thalmann Healthcare Conference on Thursday, September 29 at 12:30 p.m. E.T.

A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference.

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate, LUMRYZ™, is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Courtney Turiano
Stern Investor Relations, Inc.
Courtney.Turiano@sternir.com
(212) 698-8687

Media Contact:
Gabriella Greig
Real Chemistry
ggreig@realchemistry.com
(203) 249-2688

Staff

Recent Posts

Coro Medical Prepares to Roll Out Project AED365 Nationwide Donation Initiative

Project AED365 Aims to Empower Communities, Youth Organizations, First Responders, and more by Providing Lifesaving Automated…

22 minutes ago

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Filing of F-4 Registration Statement with the SEC Ahead of Proposed Merger

The proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates in advanced stages…

22 minutes ago

Blazesoft Spreads Holiday Cheer with $250,000 Donation to Mackenzie Health Foundation

This heartfelt donation demonstrates Blazesoft's commitment to corporate social responsibility with a generous gift to…

22 minutes ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

GOLETA, Calif.--(BUSINESS WIRE)--$INGN #AirwayClearance--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products…

3 hours ago

Bemax Inc. Announces Second Quarter Financial Results

- Revenue grew to $1,078,090, an increase of over $1million year-over-yearDallas, Georgia--(Newsfile Corp. - December…

3 hours ago

U.S. EHR Giants Drive Global Healthcare Digital Transformation Across 39 Countries, 2025 Black Book Reports

Epic, Oracle Health, MEDITECH and Altera Digital Health are redefining healthcare IT worldwide, as highlighted…

3 hours ago